Annual FCF
-$21.05 M
-$6.96 M-49.42%
31 December 2023
Summary:
Context Therapeutics annual free cash flow is currently -$21.05 million, with the most recent change of -$6.96 million (-49.42%) on 31 December 2023. During the last 3 years, it has fallen by -$20.01 million (-1934.37%). CNTX annual FCF is now -1934.37% below its all-time high of -$1.03 million, reached on 31 December 2020.CNTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$16.69 M
-$13.33 M-397.37%
01 September 2024
Summary:
Context Therapeutics quarterly free cash flow is currently -$16.69 million, with the most recent change of -$13.33 million (-397.37%) on 01 September 2024. Over the past year, it has dropped by -$13.23 million (-382.26%). CNTX quarterly FCF is now -38181.19% below its all-time high of -$43.60 thousand, reached on 30 September 2021.CNTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$31.63 M
-$13.23 M-71.88%
01 September 2024
Summary:
Context Therapeutics TTM free cash flow is currently -$31.63 million, with the most recent change of -$13.23 million (-71.88%) on 01 September 2024. Over the past year, it has dropped by -$13.88 million (-78.22%). CNTX TTM FCF is now -16780.58% below its all-time high of -$187.40 thousand, reached on 31 March 2020.CNTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.4% | -382.3% | -78.2% |
| 3 y3 years | -1934.4% | -10000.0% | -641.9% |
| 5 y5 years | - | - | - |
CNTX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1934.4% | at low | <-9999.0% | at low | -641.9% | at low |
| 5 y | 5 years | -1934.4% | at low | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | -1934.4% | at low | <-9999.0% | at low | <-9999.0% | at low |
Context Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.69 M(+397.4%) | -$31.63 M(+71.9%) |
| June 2024 | - | -$3.36 M(-23.0%) | -$18.40 M(-6.5%) |
| Mar 2024 | - | -$4.36 M(-39.7%) | -$19.68 M(-6.5%) |
| Dec 2023 | -$21.05 M(+49.4%) | -$7.23 M(+108.8%) | -$21.05 M(+18.6%) |
| Sept 2023 | - | -$3.46 M(-25.3%) | -$17.75 M(-0.2%) |
| June 2023 | - | -$4.63 M(-19.2%) | -$17.78 M(+11.4%) |
| Mar 2023 | - | -$5.73 M(+45.8%) | -$15.96 M(+13.3%) |
| Dec 2022 | -$14.09 M | -$3.93 M(+12.5%) | -$14.09 M(-6.8%) |
| Sept 2022 | - | -$3.49 M(+24.5%) | -$15.12 M(+29.6%) |
| June 2022 | - | -$2.81 M(-27.2%) | -$11.67 M(+4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.86 M(-22.3%) | -$11.19 M(+23.6%) |
| Dec 2021 | -$9.05 M(+774.7%) | -$4.96 M(>+9900.0%) | -$9.05 M(+112.2%) |
| Sept 2021 | - | -$43.60 K(-98.1%) | -$4.26 M(-6.7%) |
| June 2021 | - | -$2.33 M(+35.8%) | -$4.57 M(+78.4%) |
| Mar 2021 | - | -$1.72 M(+874.6%) | -$2.56 M(+147.7%) |
| Dec 2020 | -$1.03 M(-63.5%) | -$176.00 K(-49.7%) | -$1.03 M(+20.5%) |
| Sept 2020 | - | -$350.20 K(+9.1%) | -$858.60 K(+68.9%) |
| June 2020 | - | -$321.00 K(+71.3%) | -$508.40 K(+171.3%) |
| Mar 2020 | - | -$187.40 K | -$187.40 K |
| Dec 2019 | -$2.84 M | - | - |
FAQ
- What is Context Therapeutics annual free cash flow?
- What is the all time high annual FCF for Context Therapeutics?
- What is Context Therapeutics annual FCF year-on-year change?
- What is Context Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Context Therapeutics?
- What is Context Therapeutics quarterly FCF year-on-year change?
- What is Context Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Context Therapeutics?
- What is Context Therapeutics TTM FCF year-on-year change?
What is Context Therapeutics annual free cash flow?
The current annual FCF of CNTX is -$21.05 M
What is the all time high annual FCF for Context Therapeutics?
Context Therapeutics all-time high annual free cash flow is -$1.03 M
What is Context Therapeutics annual FCF year-on-year change?
Over the past year, CNTX annual free cash flow has changed by -$6.96 M (-49.42%)
What is Context Therapeutics quarterly free cash flow?
The current quarterly FCF of CNTX is -$16.69 M
What is the all time high quarterly FCF for Context Therapeutics?
Context Therapeutics all-time high quarterly free cash flow is -$43.60 K
What is Context Therapeutics quarterly FCF year-on-year change?
Over the past year, CNTX quarterly free cash flow has changed by -$13.23 M (-382.26%)
What is Context Therapeutics TTM free cash flow?
The current TTM FCF of CNTX is -$31.63 M
What is the all time high TTM FCF for Context Therapeutics?
Context Therapeutics all-time high TTM free cash flow is -$187.40 K
What is Context Therapeutics TTM FCF year-on-year change?
Over the past year, CNTX TTM free cash flow has changed by -$13.88 M (-78.22%)